2018
Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma
LO RE, Oriana; C. FUSILLI; F. RAPPA; M. VAN HAELE; J. DOUET et. al.Základní údaje
Originální název
Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma
Autoři
LO RE, Oriana; C. FUSILLI; F. RAPPA; M. VAN HAELE; J. DOUET; J. PINDJAKOVA; S.W. ROCHA; I. PATA; Barbora VALČÍKOVÁ; Stjepan ULDRIJAN; R.S. YEUNG; C.A. PEIXOTO; T. ROSKAMS; M. BUSCHBECK; T. MAZZA a M. VINCIGUERRA
Vydání
Hepatology, Philadelphia, Saunders, 2018, 0270-9139
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30219 Gastroenterology and hepatology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 14.971
Kód RIV
RIV/00216224:14110/18:00102119
Organizační jednotka
Lékařská fakulta
UT WoS
000422694900020
EID Scopus
2-s2.0-85039753345
Klíčová slova anglicky
histone variants; epigenetics; hepatocellular carcinoma; cancer stem cells
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 10. 2. 2019 14:50, Soňa Böhmová
Anotace
V originále
Hepatocellular carcinomas (HCC) contain a subpopulation of cancer stem cells (CSCs), which exhibit stem cell-like features and are responsible for tumor relapse, metastasis, and chemoresistance. The development of effective treatments for HCC will depend on a molecular-level understanding of the specific pathways driving CSC emergence and stemness. MacroH2A1 is a variant of the histone H2A and an epigenetic regulator of stem-cell function, where it promotes differentiation and, conversely, acts as a barrier to somatic-cell reprogramming. Here, we focused on the role played by the histone variant macroH2A1 as a potential epigenetic factor promoting CSC differentiation. In human HCC sections we uncovered a significant correlation between low frequencies of macroH2A1 staining and advanced, aggressive HCC subtypes with poorly differentiated tumor phenotypes. Using HCC cell lines, we found that short hairpin RNA-mediated macroH2A1 knockdown induces acquisition of CSC-like features, including the growth of significantly larger and less differentiated tumors when injected into nude mice. MacroH2A1-depleted HCC cells also exhibited reduced proliferation, resistance to chemotherapeutic agents, and stem-like metabolic changes consistent with enhanced hypoxic responses and increased glycolysis. The loss of macroH2A1 increased expression of a panel of stemness-associated genes and drove hyperactivation of the nuclear factor kappa B p65 pathway. Blocking phosphorylation of nuclear factor kappa B p65 on Ser536 inhibited the emergence of CSC-like features in HCC cells knocked down for macroH2A1. Conclusion: The absence of histone variant macroH2A1 confers a CSC-like phenotype to HCC cells in vitro and in vivo that depends on Ser536 phosphorylation of nuclear factor kappa B p65; this pathway may hold valuable targets for the development of CSC-focused treatments for HCC.